JEFF R FINKENSTAEDT
Podiatric Medicine & Surgery Service Providers|Podiatrist|Primary Podiatric Medicine TULSA, OK NPI 1013915701
Browse related groups: Podiatric Medicine & Surgery Service Providers|Podiatrist|Primary Podiatric Medicine OK Averitas Pharma Inc. All categories
General Payments — all program years on this page
$758.53
- Category: General Payments
- Program years: PY2018–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $244.04 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $244.04 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Averitas Pharma Inc. | $153.63 | 2 |
| Nevro Corp. | $31.45 | 2 |
| Amgen Inc. | $22.48 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $20.22 | 1 |
| Paratek Pharmaceuticals, Inc. | $16.26 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092598655 | Boston Scientific Corporation | $20.22 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111574934 | Amgen Inc. | $22.48 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113899905 | Paratek Pharmaceuticals, Inc. | $16.26 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130738022 | Nevro Corp. | $14.02 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130738024 | Nevro Corp. | $17.43 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133425979 | Averitas Pharma Inc. | $20.80 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133425983 | Averitas Pharma Inc. | $132.83 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.